Oct 2026· ACS Synthetic Biology· Vol 15 10, pp.
4132-4144
· 0 citations· 56 references
Medicine
TL;DR
BiMTBind is a domain-guided multimodal deep learning framework that integrates bidirectional state-space modeling with Transformer-based attention for residue-level binding site prediction, offering a scalable and generalizable approach for protein-nucleic acid binding site prediction.
Abstract
Accurate identification of protein-nucleic acid binding sites is essential for elucidating molecular mechanisms and for enabling structure-based drug discovery. Existing computational approaches struggle to jointly model sequence, structure, and domain knowledge, which limits both predictive accuracy and interpretability. We present BiMTBind, a domain-guided multimodal deep learning framework that integrates bidirectional state-space modeling with Transformer-based attention for residue-level binding site prediction. The model explicitly incorporates protein-domain annotations as biological priors to guide attention toward functionally relevant regions. Multi-source featurescontextual embeddings from protein language models and handcrafted structural descriptorsare fused via a learnable gating mechanism that adaptively weights each modality. This design enables the model to capture both global dependencies and local context. Extensive evaluations across diverse DNA and RNA benchmarks show that BiMTBind consistently outperforms state-of-the-art sequence- and structure-based methods on multiple metrics, including F1, MCC, and AUC. Case studies further show that domain-guided attention improves interpretability by aligning predicted binding residues with annotated functional domains. These results highlight the effectiveness of combining biologically informed priors with deep multimodal representation learning, offering a scalable and generalizable approach for protein-nucleic acid binding site prediction.
PNBind is presented, a multimodal deep learning framework that leverages protein language models, evolutionary information, and three-dimensional structural features via a geometric vector perceptron (GVP) backbone with an invariant point attention (IPA) layer for nucleic acid-binding site prediction.
LigRNA is presented, a graph neural network framework that predicts RNA-ligand binding sites through joint cross-modal encoding of both molecules and enables dynamic, ligand-dependent modulation of RNA nucleotide attention, capturing context-specific interaction patterns.
Xin Wang, He-Qin Zhu, Hao Li et al.· bioRxiv· 0 citations
HelixDTA is introduced, a deep learning framework featuring a parallel dual-branch architecture that independently learns representations from two distinct but complementary modalities: sequence context and complete target structures that demonstrates significant potential to empower precision drug design and accelerat...
Shang Lou, Xu-Hua Li, Yu-Jie Peng et al.· Journal of Chemical Informat...· 0 citations
AlloPoc is a novel framework that integrates multi-modal protein language model (PLM) representations with biochemical features for accurate allosteric pocket prediction and achieves state-of-the-art performance, surpassing existing methods including AlloFusion, DeepAllo, and AlloPED.
Hui-Ling Zhang, Shu-Wen Wen, Zi-Qi Xu et al.· IEEE transactions on computa...· 0 citations
Specific recognition between proteins and DNA governs essential cellular functions, yet the binding specificity of most DNA-binding proteins (DBPs) remains experimentally uncharacterized and high-throughput experimental methods still lag far behind the ever-growing protein data set. Here, we present 3M-BSIP (3-modal ba...
Comprehensive evaluations across six benchmark datasets demonstrate that MMB-DTI achieves highly competitive predictive performance, significantly outperforming state-of-the-art baselines, and highlights that coupling linear-time state space modeling with topological complementarity yields a robust and discriminative p...
Fang Fang, Jin-Jin Li, Cheng-Ye Huang et al.· IEEE transactions on computa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.